Search Results - "Ignatov, Atanas"

Refine Results
  1. 1

    Endocrine Risk Factors of Endometrial Cancer: Polycystic Ovary Syndrome, Oral Contraceptives, Infertility, Tamoxifen by Ignatov, Atanas, Ortmann, Olaf

    Published in Cancers (02-07-2020)
    “…Endometrial cancer is the most common gynecologic cancer and is predominantly endocrine-related. The role of unopposed estrogen in the development of…”
    Get full text
    Journal Article
  2. 2

    B Cells Induce Early-Onset Maternal Inflammation to Protect against LPS-Induced Fetal Rejection by Uehre, Gina Marie, Tchaikovski, Svetlana, Ignatov, Atanas, Zenclussen, Ana Claudia, Busse, Mandy

    “…The maternal balance between B regulatory (Breg) cells and inflammatory B cells is of central importance for protection against preterm birth (PTB). However,…”
    Get full text
    Journal Article
  3. 3

    The 3D in vivo chorioallantoic membrane model and its role in breast cancer research by Kohl, Cynthia, Aung, Thiha, Haerteis, Silke, Ignatov, Atanas, Ortmann, Olaf, Papathemelis, Thomas

    “…Purpose We aimed to evaluate the role of the chorioallantoic membrane model (CAM) in breast cancer research. Methods The following is an overview of the use of…”
    Get full text
    Journal Article
  4. 4

    Survival benefit of tamoxifen in male breast cancer: prospective cohort analysis by Eggemann, Holm, Brucker, Cosima, Schrauder, Michael, Thill, Marc, Flock, Felix, Reinisch, Mattea, Costa, Serban-Dan, Ignatov, Atanas

    Published in British journal of cancer (07-07-2020)
    “…Background Due to the lack of prospective data, current treatment of male breast cancer (MBC) is based on information obtained from retrospective analysis or…”
    Get full text
    Journal Article
  5. 5

    Role of GPR30 in the mechanisms of tamoxifen resistance in breast cancer MCF-7 cells by Ignatov, Atanas, Ignatov, Tanja, Roessner, Albert, Costa, Serban Dan, Kalinski, Thomas

    Published in Breast cancer research and treatment (01-08-2010)
    “…Tamoxifen is the most frequently used anti-hormonal drug for treatment of women with hormone-dependent breast cancer. The aim of this study is to investigate…”
    Get full text
    Journal Article
  6. 6

    GPER-1 expression is associated with a decreased response rate to primary tamoxifen therapy of breast cancer patients by Ignatov, Tanja, Treeck, Oliver, Kalinski, Thomas, Ortmann, Olaf, Ignatov, Atanas

    Published in Archives of gynecology and obstetrics (01-02-2020)
    “…Purpose Endocrine therapies using tamoxifen and/or aromatase inhibitors are important therapeutic options for the targeted treatment of hormone-responsive…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Minimal-invasive or open approach for surgery of early cervical cancer: the treatment center matters by Gennari, Paolo, Gerken, Michael, Mészáros, József, Klinkhammer-Schalke, Monika, Ortmann, Olaf, Eggemann, Holm, Ignatov, Atanas

    Published in Archives of gynecology and obstetrics (01-08-2021)
    “…Purpose The aim of the study was to compare recurrence-free survival (RFS) and overall survival (OS) of patients with early stage cervical cancer in dependence…”
    Get full text
    Journal Article
  10. 10

    Adjuvant chemotherapy for breast cancer patients with axillary lymph node micrometastases by Hetterich, Madeleine, Gerken, Michael, Ortmann, Olaf, Inwald, Elisabeth C., Klinkhammer-Schalke, Monika, Eggemann, Holm, Ignatov, Atanas

    Published in Breast cancer research and treatment (01-06-2021)
    “…Background The axillary lymph node status is one of the most important prognostic factors in patients with early breast cancer. However, the impact of axillary…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Tamoxifen treatment for male breast cancer and risk of thromboembolism: prospective cohort analysis by Eggemann, Holm, Bernreiter, Anna-Lena, Reinisch, Mattea, Loibl, Sibylle, Taran, Florin-Andrei, Costa, Serban-Dan, Ignatov, Atanas

    Published in British journal of cancer (05-02-2019)
    “…Purpose Thromboembolism is a common adverse event in women treated with tamoxifen (TAM) for breast cancer. The risk in male breast cancer patients is poorly…”
    Get full text
    Journal Article
  13. 13

    Comparison of survival of patients with endometrial cancer undergoing sentinel node biopsy alone or systematic lymphadenectomy by Ignatov, Atanas, Papathemelis, Thomas, Ivros, Stylianos, Ignatov, Tanja, Ortmann, Olaf, Eggemann, Holm

    Published in Archives of gynecology and obstetrics (01-10-2020)
    “…Background Recently, sentinel lymph node mapping was introduced in the surgical staging of endometrial cancer as alternative to systematic lymphadenectomy…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Systematic lymphadenectomy in early stage endometrial cancer by Ignatov, Atanas, Ivros, Stylianos, Bozukova, Mihaela, Papathemelis, Thomas, Ortmann, Olaf, Eggemann, Holm

    Published in Archives of gynecology and obstetrics (01-07-2020)
    “…Background The positive effect of systematic lymphadenectomy on survival of patients with endometrial cancer is a topic of ongoing debate. Methods We aimed to…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Value of indocyanine green pelvic lymph node mapping in the surgical approach of cervical cancer by Papathemelis, Thomas, Scharl, Anton, Anapolski, Michael, C. Inwald, Elisabeth, Ignatov, Atanas, Ortmann, Olaf, Gerken, Michael, Klinkhammer-Schalke, Monika, Scharl, Sophia

    Published in Archives of gynecology and obstetrics (01-03-2020)
    “…Purpose Lymph node metastasis is a significant predictive factor for disease recurrence and survival in cervical cancer patients and relevant for therapeutic…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20